Authors:
Paciaroni, K
Rossi, E
Bazzan, M
Ireland, H
De Stefano, V
Citation: K. Paciaroni et al., Prevalence of the C536T mutation in the tissue factor pathway inhibitor (TFPI) gene among patients with venous thromboembolic disease, THROMB HAEM, 85(5), 2001, pp. 938-939
Authors:
Agnelli, G
Prandoni, P
Santamaria, MG
Bagatella, P
Iorio, A
Bazzan, M
Moia, M
Guazzaloca, G
Bertoldi, A
Tomasi, C
Scannapieco, G
Ageno, W
Ascani, A
Villalta, S
Frulla, M
Mosena, L
Girolami, A
Vaccarino, A
Alatri, A
Palareti, G
Marchesi, M
Ambrosio, GB
Parisi, R
Doria, S
Steidl, L
Ambrosini, F
Silingardi, M
Ghirarduzzi, A
Iori, I
Citation: G. Agnelli et al., Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis., N ENG J MED, 345(3), 2001, pp. 165-169
Citation: C. Sada et al., On the dynamics of periodically-poled lithium niobate formation by off-center Czochralski technique, APPL PHYS L, 79(14), 2001, pp. 2163-2165
Authors:
Bazzan, M
Tamponi, G
Schinco, P
Vaccarino, A
Foli, C
Gallone, G
Pileri, A
Citation: M. Bazzan et al., Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemia, ANN HEMATOL, 78(12), 1999, pp. 539-543
Authors:
Michiels, JJ
Kutti, J
Stark, P
Bazzan, M
Gugliotta, L
Marchioli, R
Griesshammer, M
van Genderen, PJJ
Briere, J
Kiladjian, JJ
Barbui, T
Finazzi, G
Berlin, NI
Pearson, TC
Green, AC
Fruchtmann, SM
Silver, RT
Hansmann, E
Wehmeier, A
Lengfelder, E
Landolfi, R
Kvasnicka, HM
Hasselbalch, H
Cervantes, F
Reilly, JT
Demory, JL
Gisslinger, H
Guardiola, P
Martyre, MC
Le Bousse-Kerdiles, MC
Thiele, J
Citation: Jj. Michiels et al., Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis, NETH J MED, 54(2), 1999, pp. 46-62